Abstract
Purpose
To evaluate the Vitamin D status of patients with a single autoimmune disease and of patients with several autoimmune diseases.
Methods
We enrolled 35 patients with isolated type 1 diabetes mellitus (T1DM), 60 with autoimmune polyendocrine syndromes (APS) including T1DM and 72 control subjects. Among patients with APS, 10 were classified as type 2 (Addison’s disease + T1DM), whereas the other 50 as type 3 (autoimmune thyroid disease + T1DM + other autoimmune diseases). Vitamin D (25-OHD) levels were assessed by a chemiluminescent immunoassay in all patients and controls on samples drawn in the morning of the same months.
Results
Both groups of APS and T1DM patients showed 25-OHD levels significantly lower than healthy controls (p < 0.001 for both vs controls), without any significant difference between the two groups (p = 0.80). The highest prevalence of vitamin D deficiency (values <20 ng/ml) was observed in APS type 3 subgroup (8 out of 50 patients, 16 %).
Conclusions
Patients with APS present reduced vitamin D circulating levels, but the vitamin D status is not different between patients with single or multiple autoimmune diseases. The kind of autoimmune disease, rather than the association of several autoimmune diseases, may influence negatively the levels of vitamin D. Further prospective studies are needed to clarify if impaired vitamin D level is a causal factor in the pathogenesis of autoimmune diseases or a consequence of them.
Similar content being viewed by others
References
Yang CY, Leung PS, Adamopoulos IE, Gershwin ME (2013) The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allerg Immunol 45:217–226
Pludowski P, Holick MF, Pilz S et al (2013) Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality––a review of recent evidence. Autoimmun Rev 12:976–989
Prietl B, Treiber G, Pieber TR, Amrein K (2013) Vitamin D and immune function. Nutrients 5:2502–2521
Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP (2004) Genetics and biology of vitamin D receptor polymorphism. Gene 338:143–156
Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57:1308–1310
Provvedini DM, Tsoukas CD, Detos LJ, Manolagas SC (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181–1183
Veldman CM, Cantorna MT, De Luca HF (2000) Expression of 1,25 dihydroxyvitamin D (3) receptor in the immune system. Arch Biochem Biophys 374:334–338
De Luca HF, Cantorna MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15:2579–2585
Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM (2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324:23–33
Saggese G, Federico G, Balestri M, Toniolo A (1989) Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J Endocrinol Invest 12:329–335
Wu S, Cantorna MT (2008) The vitamin D receptor is required for iNKT cell development. Proc Nat Acad Sci USA 105:5207–5212
Tamer G, Arik S, Tamer I, Coksert D (2011) Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid 21:891–896
Camurdan OM, Doger E, Bideci A, Celik N, Cinaz P (2012) Vitamin D status in children with Hashimoto thyroiditis. J Pediatr Endocrinol Metab 25:467–470
Ramos Lopez E, Zwermann O, Segni M et al (2004) A promoter polymorphism of the CYP 27B1 gene is associated with Addison’s disease, Hashimoto’s thyroiditis, Graves’ disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol 151:193–197
Bozkurt NC, Karbek B, Ucan B et al (2013) The association between severity of vitamin D deficiency and Hashimoto’s thyroiditis. Endocr Pract 19:479–484
Ramogopalan SV, Goldacre R, Disanto G, Giovannoni G, Goldacre MJ (2013) Hospital admission for vitamin D related conditions and subsequent immune-mediated disease: record-linkage study. BMC Med 11:171
Balla B, Tobiás B, Kósa JP et al (2014) Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer. J Endocrinol Invest. doi:10.1007/s40618-014-0165-7
Feng M, Li H, Chen SF, Li WF, Zhang FB (2013) Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 43:318–326
Kebapcilar AG, Kulaksizoglu M, Kebapcilar L et al (2013) Is there a link between premature ovarian failure and serum concentrations of vitamin D, zinc, and copper? Menopause 20:94–99
Holick M (2007) Vitamin D deficiency. N Engl J Med 357:266–281
Orgaz-Molina J, Buendia-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S (2012) Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients. J Am Acad Dermatol 67:931–938
Neufeld M, Blizzard RM (1980) Polyglandular autoimmune diseases. In: Pinchera A, Doniach D, Fenzi GF, Baschieri L (eds) Symposium on autoimmune aspects of endocrine disorders. Academic, New York, pp 357–365
Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23:327–364
De Bellis A, Pane E, Bellastella G et al (2011) Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism. Clin Endocrinol 75:361–366
Holick MF, Binkley NC, Bischoff-Ferrari HA et al (2011) An Endocrine Society clinical practice guideline. Evaluation, treatment and prevention of vitamin D deficiency. J Clin Endocrinol Metab 96:1911–1930
Rosen CJ, Abrams SA, Aloia JF et al (2012) IOM committee members respond to Endocrine Society vitamin D guideline. J Clin Endocrinol Metab 97:1146–1152
Buschur E, Sarma AV, Pietropaolo M et al (2014) Self-reported autoimmune disease by sex in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care 37:e28–e29
Conflict of interest
Nothing to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bellastella, G., Maiorino, M.I., Petrizzo, M. et al. Vitamin D and autoimmunity: what happens in autoimmune polyendocrine syndromes?. J Endocrinol Invest 38, 629–633 (2015). https://doi.org/10.1007/s40618-014-0233-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-014-0233-z